First-Line Treatment with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Improves Overall Survival (OS) in Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Randomized Phase III Trial O

Konference: 2009 51th ASH Annual Meeting – účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: Chronic Lymphocytic Leukemia

Číslo abstraktu: 535

Autoři: Prof. MD Michael Hallek; Guenter Fingerle-Rowson; MD Anna-Maria Fink; Dipl.Math. Raymonde Busch, Ph.D.; prof. MUDr. Jiří Mayer, CSc.; Manfred Hensel; Georg Hopfinger; MD Georg Hess; Ulrich von Gruenhagen; Manuela A. Bergmann; MBBS John V. Catalano, FRACP FRCPA; Pier Luigi Zinzano; MD Federico Caligaris Cappio; Prof. John Francis Seymour, MD, PhD, MBBS, FRACP

Datum přednesení příspěvku: 5. 12. 2009